Alfuzosin and Symptoms of Chronic Prostatitis–Chronic Pelvic Pain Syndrome
Author(s) -
J. Curtis Nickel,
John N. Krieger,
Mary McNaughtonCollins,
Rodney U. Anderson,
Michel A. Pontari,
Daniel A. Shoskes,
Mark S. Litwin,
Richard B. Alexander,
Paige White,
Richard E. Berger,
Robert B. Nadler,
Michael P. O’Leary,
Men Long Liong,
Scott I. Zeitlin,
Shan Chuai,
J. Richard Landis,
John W. Kusek,
Leroy M. Nyberg,
Anthony J. Schaeffer
Publication year - 2008
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0803240
Subject(s) - prostatitis , alfuzosin , medicine , pelvic pain , chronic prostatitis/chronic pelvic pain syndrome , chronic pain , physical therapy , urology , surgery , prostate , lower urinary tract symptoms , cancer
In men with chronic prostatitis-chronic pelvic pain syndrome, treatment with alpha-adrenergic receptor blockers early in the course of the disorder has been reported to be effective in some, but not all, relatively small randomized trials.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom